1. Home
  2. BANL vs GDTC Comparison

BANL vs GDTC Comparison

Compare BANL & GDTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BANL

CBL International Limited

HOLD

Current Price

$0.37

Market Cap

11.7M

Sector

Energy

ML Signal

HOLD

Logo CytoMed Therapeutics Limited

GDTC

CytoMed Therapeutics Limited

HOLD

Current Price

$0.94

Market Cap

15.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BANL
GDTC
Founded
2015
2018
Country
Malaysia
Singapore
Employees
N/A
N/A
Industry
Oil Refining/Marketing
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.7M
15.5M
IPO Year
2023
2023

Fundamental Metrics

Financial Performance
Metric
BANL
GDTC
Price
$0.37
$0.94
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
38.5K
38.0K
Earning Date
09-04-2025
04-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$580,456,800.00
$573,193.00
Revenue This Year
N/A
$5.37
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
11.38
63.03
52 Week Low
$0.30
$0.89
52 Week High
$1.30
$3.68

Technical Indicators

Market Signals
Indicator
BANL
GDTC
Relative Strength Index (RSI) 31.81 20.48
Support Level $0.30 $0.89
Resistance Level $0.44 $1.39
Average True Range (ATR) 0.04 0.13
MACD -0.00 -0.04
Stochastic Oscillator 43.04 7.13

Price Performance

Historical Comparison
BANL
GDTC

About BANL CBL International Limited

CBL International Ltd is a marine fuel logistics company that provides a one-stop solution for vessel refueling. In the bunkering industry, it is referred to as a bunkering facilitator. It facilitates vessel refueling between ship operators and local physical distributors/traders by purchasing marine fuel, including fossil fuel and alternative fuel, from its suppliers and arranging for the suppliers to deliver the fuel to the customers. The company's customer base comprises container liners, bulk carriers, and tankers. Geographically, the company generates a majority of its revenue from China, followed by Hong Kong, Malaysia, Singapore, South Korea, and other regions.

About GDTC CytoMed Therapeutics Limited

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.

Share on Social Networks: